Artiva Biotherapeutics (ARTV) Return on Sales (2023 - 2024)
Artiva Biotherapeutics (ARTV) reported Return on Sales of 2.47% for Q4 2024, down 254.0% year-over-year from 1.6% in Q1 2024, and down 1438.33% quarter-over-quarter from 0.16% in Q3 2024.
Artiva Biotherapeutics (ARTV) Return on Sales (2023 - 2024) Analysis & Trends
Artiva Biotherapeutics (ARTV) has 2 years of Return on Sales data on file, last reported at 2.47% in Q4 2024.
- Return on Sales for Q4 2024 came in at 2.47%, down 254.0% year-over-year; the trailing twelve-month figure through Dec 2024 was 2.47% (changed N/A YoY), and the FY2024 annual result was 2.6%, down 260.0% from the prior year.
- Return on Sales declined to 2.47% in Q4 2024 per ARTV's latest filing, from 0.16% in the prior quarter.
- Over five years, Return on Sales peaked at 0.07% in Q4 2023 and troughed at 2.47% in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.00% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 0.00% |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 0.00% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Artiva Biotherapeutics | 241.85 Mn | 241.85 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -2.47% |
| Sep 30, 2024 | -0.16% |
| Jun 30, 2024 | 0.00% |
| Mar 31, 2024 | -0.55% |
| Dec 31, 2023 | 0.07% |
| Sep 30, 2023 | 0.00% |
| Jun 30, 2023 | -0.03% |